ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,823.30
-0.47%
S&P ASX All Technology
3,448.70
-0.76%
Brent Oil
70.155
-0.71%
US Dollar vs AUD
1.57181
0.31%
Bitcoin
82,775.17
-1.67%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Imerys (NK) Share Price

Imerys

Imerys (NK)

EU
33.16
0.62
(1.91%)
Closed 19 March 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
33.16
Bid
32.80
Offer
33.40
Volume
57,149
32.72 Day's Range 33.32
25.54 52 Week Range 38.50
Market Cap
2.798B
Previous Close
32.54
Open
32.82
Last Trade
3
@
33.16
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
96,801
Shares Outstanding
84,367,933
Dividend Yield
4.07%
PE Ratio
-29.45
Earnings Per Share (EPS)
-1.13
Revenue
3.64B
Net Profit
-95M

About Imerys

Sector
Minrls,earths-ground,treated
Industry
Structural Clay Products
Website
www.imerys.com
Headquarters
Paris, Paris, Fra
Founded
1880
Imerys is listed in the Minrls,earths-ground,treated sector of the Euronext with ticker NK. The last closing price for Imerys was 32.54 €. Over the last year, Imerys shares have traded in a share price range of 25.54 € to 38.50 €.

Imerys currently has 84,367,933 shares in issue. The market capitalisation of Imerys is 2.75 € billion. Imerys has a price to earnings ratio (PE ratio) of -29.45.

Ask ADVFN Intelligence (AI)

NK Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.143.5602748282332.0233.3231.285977532.02221276DE
44.7616.760563380328.434.5427.3213352130.70732408DE
126.0422.271386430727.1234.5425.549680129.09918954DE
263.9213.406292749729.2434.5425.548818829.19034401DE
523.3611.275167785229.838.525.548498231.0469314DE
156-6.74-16.892230576439.943.2223.28452132.70698453DE
26010.7447.903657448722.4246.8220.98994233.81780574DE

NK - Frequently Asked Questions (FAQ)

What is the current Imerys share price?
The current share price of Imerys is 33.16 €
How many Imerys shares are in issue?
Imerys has 84,367,933 shares in issue
What is the market cap of Imerys?
The market capitalisation of Imerys is EUR 2.75B
What is the 1 year trading range for Imerys share price?
Imerys has traded in the range of 25.54 € to 38.50 € during the past year
What is the PE ratio of Imerys?
The price to earnings ratio of Imerys is -29.45
What is the cash to sales ratio of Imerys?
The cash to sales ratio of Imerys is 0.77
What is the reporting currency for Imerys?
Imerys reports financial results in EUR
What is the latest annual turnover for Imerys?
The latest annual turnover of Imerys is EUR 3.64B
What is the latest annual profit for Imerys?
The latest annual profit of Imerys is EUR -95M
What is the registered address of Imerys?
The registered address for Imerys is 43, QUAI DE GRENELLE, PARIS, PARIS, 75015
What is the Imerys website address?
The website address for Imerys is www.imerys.com
Which industry sector does Imerys operate in?
Imerys operates in the STRUCTURAL CLAY PRODUCTS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLCOTCoretech 5
0.051 €
(82.14%)
52.15k
PHXMPHAXIAM Therapeutics SA
0.31 €
(82.14%)
170.47k
FOUFountain
1.57 €
(19.85%)
10.17k
ALLAMLlama Group SA
0.69 €
(17.75%)
214.94k
NANONanobiotix
3.468 €
(17.56%)
834.5k
LUDSLucibel DS
0.0001 €
(-75.00%)
525.6k
LU0110790085Bip Investment Partners Sa
0.05 €
(-64.29%)
318
ALCYBCybergun
0.0001 €
(-50.00%)
902.08M
ALEUPEuroplasma
0.0133 €
(-21.76%)
161.79M
MLPHOPhotonike Capital
0.104 €
(-16.80%)
800
ATOAtos SE
0.0038 €
(-7.32%)
1.2B
ALCYBCybergun
0.0001 €
(-50.00%)
902.08M
ALEUPEuroplasma
0.0133 €
(-21.76%)
161.79M
BCPBanco Comercial Portugues SA
0.578 €
(3.07%)
86.84M
ALTDTonner Drones
0.0218 €
(-5.22%)
28.2M

Discussion

View Full Feed
trader59 trader59 2 minutes ago
Only if you read it unbiased, something I bet is not possible for you.
Yes, Biden turned them down, but not for "political reasons," as Musk claimed. They made the decision in August of 2024 to get them in February. It's right there in the first fact check, and in yours, the astronaut said he
FNMAUP FNMAUP 4 minutes ago
Everybody thinking this week for uplist to NYSE or still more trolls to fire first? Boatload of more press releases on moves. Most I have seen in years.
FNMA
northam43 northam43 4 minutes ago
Report #1 Status Report.

https://investorshub.advfn.com/uimage/uploads/2025/3/18/svfar1_Status_Report.png
ron_66271 ron_66271 4 minutes ago
I Have Already Provided The Numbers.

Now just let this happen.



Ron
COOP
mmayr mmayr 4 minutes ago
Price Surge Ahead: Trump Announces Both Reciprocal and Sectoral Tariffs Coming April 2

[yt]EvXAEvl3F5k[/yt]

https://www.youtube.com/watch?v=EvXAEvl3F5k
northam43 northam43 5 minutes ago
Report #1 Status Report.

https://investorshub.advfn.com/uimage/uploads/2025/3/18/svfar1_Status_Report.png
crazy horse 0 crazy horse 0 5 minutes ago
They must have something Big lined up !


Well, isn't it obvious?

They must not need or desire retail investors. What pharmaceutical company or any legit company for that matter has an abandoned website, zero PR/filing updates, zero clarity on direction and desire
RSPI
trader59 trader59 5 minutes ago
delete please
janice shell janice shell 5 minutes ago
What "laptop story" are you talking about? Wasn't me.
rayovac812 rayovac812 6 minutes ago
Anavex Life Sciences has already spent $1.5 million on the manufacturing of blarcamesine product for sales in the EU, etc.

It goes in line with inside exec's buying shares. Gives an appearance they are confident they will get approval.
AVXL
janice shell janice shell 6 minutes ago
lol, Tiffany doesn't work for Paul. Someone who looks like her works for Paul.
blackcat blackcat 7 minutes ago
And some of these judges are getting downright angry.

?MeidasTouch? ?
·

In a scathing ruling, a federal judge has blocked Trump transgender military ban, calling it "soaked in animus and dripping with pretext." Judge Reyes says the ban demeans transgender people
hedge_fun hedge_fun 7 minutes ago
The astronaut is home. Let’s see CNN…..

CONduct the interview and get to the bottom of it.

BTW, who was it that posted the laptop story that was censored?

It’s rhetorical.
georgie18 georgie18 7 minutes ago
RLAY...$3.36...🥳...

georgie18

Member Level
Re: georgie18 post# 12

Tuesday, March 18, 2025 9:39:06 AM

Post#
14
of 14
RLAY...$3.30...Added here...🥳

georgie18

Member
RLAY
georgie18 georgie18 7 minutes ago
RLAY...$3.36...🥳...

georgie18

Member Level
Re: georgie18 post# 12

Tuesday, March 18, 2025 9:39:06 AM

Post#
14
of 14
RLAY...$3.30...Added here...🥳

georgie18

Member
RLAY
georgie18 georgie18 7 minutes ago
RLAY...$3.36...🥳...

georgie18

Member Level
Re: georgie18 post# 12

Tuesday, March 18, 2025 9:39:06 AM

Post#
14
of 14
RLAY...$3.30...Added here...🥳

georgie18

Member
RLAY
fuagf fuagf 7 minutes ago
I do. Still like life more than nothing. ;-)
MrMike241 MrMike241 8 minutes ago
Whoa. OK. If Trump's daughter works for Rand Paul then the very notion that he would dissent from Trump tariffs and attempt to recruit others feels like a loyalty test. Trump is definitely paranoid enough to issue constant loyalty tests. Things that make you go hmm 🤔

Damn Jani
martyDg martyDg 8 minutes ago
A request for increase in authorized share count is coming in a few months. And then a lawsuit from a few shareholders!
If she better have MAA approval by the time she ask for an increase or shareholders will tell her "F••k You! Go back to your cave, take your request with you and shove it in
NWBO
janice shell janice shell 8 minutes ago
All that is true, and we know it. Roberts reprimanded Trump just today. But will he challenge a court order? And what will happen then?

If we don't have a plan to make him cooperate, we--and the Republic--are in big trouble.

And fwiw,, Chuck Schumer will be on Chris Ha
Smitty5150 Smitty5150 8 minutes ago
With the US FDA it would have been shorter. Less than 1 year and we would have been given a PDUFA date for the decision. It was a bad choice to go the MHRA route.
NWBO
Smitty5150 Smitty5150 8 minutes ago
With the US FDA it would have been shorter. Less than 1 year and we would have been given a PDUFA date for the decision. It was a bad choice to go the MHRA route.
NWBO
SilverForest61 SilverForest61 9 minutes ago
Thanks for the info
UMAV
Lime Time Lime Time 10 minutes ago
lol. guy gets out and is continually trashing a good stock. Doesn't make any sense.

Watch this run to .05 or better
VGTL

Your Recent History

EU
NK
Imerys
BIT
NSCITOTEBOE7
Republic of Portugal
NASDAQ
BWIN
Baldwin Insurance
EU
VAF
Vista Alegre
NASDAQ
BMGL
Basel Medical
KOSPI
213500
Hansol Paper
NASDAQ
CDCYX
Ci G520 2040 Q1 Fund Cla...
USOTC
BQAZF
Bank Audi SAL (GM)
TSX
ACB.WT.V
Aurora Cannabis
LSE
B30G
2030 Usd Gbp D
NASDAQ
CBVKX
Ci Canadian Dividend Cor...
NASDAQ
FSVCX
Fidelity Advisor Sustain...
LSE
QK02
Morg.st.b.v 24
NASDAQI
OMXSLCGI
OMX Stockholm Large Cap GI
USOTC
SHECY
Shin Etsu Chemical (PK)
TSX
CSD
iShares Short Duration H...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads